Ā | Stable plaques (104 cases) | Unstable plaques (82 cases) | Odds ratio (95% CI) | P uni-variate analysis | P multi- variate analysis |
---|---|---|---|---|---|
Age (yrsāĀ±āSD) | 72.5āĀ±ā8.1 | 72.8āĀ±ā9.3 | 0.99 (0.96ā1.03) | 0.80 | 0.87 |
Gender | Ā | Ā | Ā | Ā | Ā |
Ā Male | 65 (62.5%) | 66 (80.5%) | 0.41 (0.20ā0.82) | 0.008 | 0.01 |
Ā Female | 39 (37.5%) | 16 (19.5%) | Ā | Ā | Ā |
Hypertension acc. AHA | 90 (86.5%) | 72 (87.8%) | 1.47 (0.57ā3.84) | 0.80 | 0.42 |
Diabetes | 48 (46.2%) | 32 (39.0%) | 0.70 (0.35ā1.39) | 0.33 | 0.31 |
Smoking habit | 23 (22.1%) | 17 (20.7%) | 0.80 (0.36ā1.73) | 0.82 | 0.58 |
Hypercholesterolemia | 17 (16.3%) | 12 (14.6%) | 0.65 (0.26ā1.63) | 0.75 | 0.35 |
Hypertriglyceridemia | 35 (33.7%) | 35 (42.7%) | 1.80 (0.93ā3.63) | 0.21 | 0.10 |
Low-HDL | 48 (46.2%) | 38 (46.3%) | 1.24 (0.63ā2.45) | 0.98 | 0.53 |
Abdominal obesity | 20 (19.2%) | 9 (11.0%) | 0.47 (0.19ā1-17) | 0.12 | 0.11 |
Statins | 74 (71.2%) | 54 (65.9%) | 0.75 (0.38ā1.48) | 0.44 | 0.41 |
Anti-hypertensive drugs | 87 (83.7%) | 66 (80.5%) | 0.83 (0.36ā1.91) | 0.57 | 0.67 |
Hypertension acc. ESC | 62 (59.6%) | 50 (61.0%) | 1.16 (0.60ā2.24) | 0.85 | 0.66 |
High LDL-C | 38 (36.5%) | 33 (40.2%) | 1.17 (0.64ā2.12) | 0.61 | 0.30 |
Metabolic syndrome | 49 (47.1%) | 36 (43.9%) | 0.91 (0.49ā1.71) | 0.66 | 0.77 |